Cronos Group Inc. (CRON) Comparison with companies in other sectors?

Cronos Group Inc. has a share price of 385.42M. You can analyze Cronos Group Inc. (CRON) competitors across different market sectors through stock heatmaps.

What are CRON's NET and operating margins?

Cronos Group Inc. (CRON) operating margin is around -0.47, and net profit margin is approximately 0.36 as of the latest reports.

In what way does CRON's earnings per share (EPS) trend reflect its financial momentum?

Cronos Group Inc. (CRON) EPS is 0.14 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Cronos Group Inc. is 14.64, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Cronos Group Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Cronos Group Inc. like P/E which is 15.84, P/B which is 0.73, and PEG which is 0.53. Compare them with sector averages to evaluate if the stock is priced fairly.

Cronos Group Inc.

CRON•NASDAQ

Healthcare

Drug Manufacturers - Specialty & Generic

$2.05

$-0.02(-0.97%)

Fundamental Analysis of Cronos Group Inc. (CRON)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$0.14

P/E Ratio

14.64

ROE

0.05%

Net Margin

0.36%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$790.11M

Shares OutstandingTotal number of shares issued

$385.42M

Book Value/ShareNet worth per share

$2.91

Revenue/ShareAnnual revenue per share

$0.35

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.14

Net MarginNet income as percentage of revenue

36.50%

Operating MarginOperating income as percentage of revenue

-47.32%

ROEReturn on shareholders' equity

4.63%

ROAReturn on total assets

4.29%

ROCEReturn on capital employed

-5.72%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.02

Cash/ShareCash and equivalents per share

$2.19

FCF YieldFree cash flow as percentage of market cap

-0.96%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for CRONFinancial Ratios Analysis details for CRON are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for CRONSector Benchmarking details for CRON are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Cronos Group Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Cronos Group Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Cronos Group Inc.'s unique business strengths and challenges.

Key Financial Metrics for Cronos Group Inc.

For Cronos Group Inc., essential financial indicators include EPS 0.14, PE 14.64, and ROE 0.05. These key ratios reveal insights into Cronos Group Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Cronos Group Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Cronos Group Inc.

Metrics like Net Margin 36.50% and ROA 4.29% shed light on how well Cronos Group Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Cronos Group Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Cronos Group Inc.

Using ratios such as P/B Ratio 0.73 and PEG Ratio 0.53, investors can assess whether Cronos Group Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Cronos Group Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Cronos Group Inc.

Financial health indicators, such as Debt/Equity Ratio 0.002 and Cash Flow $-0.02, provide a snapshot of Cronos Group Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Cronos Group Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Cronos Group Inc.

Investing in Cronos Group Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Cronos Group Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;